Cargando...
Brentuximab vedotin联合氮芥治疗六例复发难治性霍奇金淋巴瘤疗效分析
OBJECTIVE: To observe the clinical efficacy and side effects of brentuximab vedotin (BV) plus chlormethine hydrochloride (CH) in patients with relapsed and refractory Hodgkin lymphoma (HL) after failure with BV alone. METHODS: From March, 2014 to December, 2014, 6 patients who failed with BV monothe...
Gardado en:
| Publicado en: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342637/ https://ncbi.nlm.nih.gov/pubmed/26304081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.010 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|